Ebru Haciosmanoglu Aldogan

Dr. Ebru Haciosmanoglu Aldogan

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2023 in Archiv der Pharmazie
Verified
Journal Article
Closed access
FTFeyzi Sinan Tokalı
Feyzi Sinan Tokalı
HŞHalil ŞENOL
Halil ŞENOL
HYHande İpEk Yetke
Hande İpEk Yetke
EAEbru Haciosmanoglu Aldogan
Ebru Haciosmanoglu Aldogan


18 February 2023 in Journal of Bioscience and Bioengineering
Verified
Journal Article
Closed access
CACevahir Altinkaynak
Cevahir Altinkaynak
EAEbru Haciosmanoglu Aldogan
Ebru Haciosmanoglu Aldogan
MEMurat Ekremoglu
Murat Ekremoglu
MHMayram Hacioglu
Mayram Hacioglu
NÖNalan Özdemir
Nalan Özdemir

1 November 2019 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
MHMayram Hacioglu
Mayram Hacioglu
EAEbru Haciosmanoglu Aldogan
Ebru Haciosmanoglu Aldogan
ABAyse Seher Birteksoz-Tan
Ayse Seher Birteksoz-Tan
CBCagla Bozkurt-Guzel
Cagla Bozkurt-Guzel
PSPaul Savage
Paul Savage

1 September 2015 in Mitochondrion
Verified
Journal Article
Closed access
EKEmine Koc
Emine Koc
EAEbru Haciosmanoglu Aldogan
Ebru Haciosmanoglu Aldogan
Pier Paolo ClaudioPier Paolo Claudio
Pier Paolo Claudio
AWAllison Wolf
Allison Wolf
LCLuigi Califano
Luigi Califano
HKHasan Koc
Hasan Koc

12 April 2022 in Life
Verified
Journal Article
Open access
PDF file
HYHande Yapışlar
Hande Yapışlar
EAEbru Haciosmanoglu Aldogan
Ebru Haciosmanoglu Aldogan
TSTurkan Sarioglu
Turkan Sarioglu
SDSEVGIN DEGIRMENCIOGLU
SEVGIN DEGIRMENCIOGLU
ISIbrahim Sogut
Ibrahim Sogut
CECem Ekmekcioglu
Cem Ekmekcioglu
Introduction: Insulin resistance is associated with a pro-inflammatory state increasing the risk for complications in patients with type 2 diabetes mellitus (T2DM). In addition to its chronobiotic effects, the pineal hormone melatonin is known to exert anti-inflammatory and antioxidant effects. Melatonin was also suggested to affect insulin secretion. The aim of this study was therefore to investigate the effect of melatonin on inflammation in diabetic rats and to study the possible involvement of the melatonin receptor, MT2. Materials and Methods: Male Sprague Dawley rats were randomly divided into four experimental groups (n = 10 per group): (1) control, (2) streptozotocin/nicotinamide induced diabetes type 2 (T2DM), (3) T2DM treated with melatonin (500 µg/kg/day), and (4) T2DM treated with melatonin (500 µg/kg/day for 6 weeks) and the selective MT2 receptor antagonist luzindole (0.25 g/kg/day for 6 weeks). Blood samples were taken for biochemical parameters and various tissue samples (liver, adipose tissue, brain) were removed for immunohistochemistry (IHC), Western blot (WB), and Q-PCR analyses, respectively. Results: Melatonin significantly reduced increased blood levels of liver transaminases (AST, ALT), blood urea nitrogen (BUN), triglyceride, very low-density lipoprotein (VLDL), and cholesterol in diabetic rats with luzindole treatment partly reversing this effect regarding the lipids. Furthermore, the liver and adipose tissues of T2DM rats treated with melatonin showed lower expression of the inflammatory markers IL-1β, IL-6, TNF-α, and NF-κB as compared to the T2DM group without melatonin. The results also showed that the MT2 receptor is at least partly involved in the protective effects of melatonin. Conclusions: Our results suggest that melatonin exerts relevant anti-inflammatory effects on various tissues in type 2 diabetic rats.